Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sabin

Showing results (441-450 of 520) with videos related to

Pageof 52
Sort By:
AIDS (London, England)|June 26, 2007
Increased duration of viral suppression is associated with lower viral rebound rates in patients with previous treatment failuresAndrew A Benzie, Loveleen K Bansi, Caroline A Sabin, et al.
Antiviral Therapy|December 1, 2005
Predictors of hypertension and changes of blood pressure in HIV-infected patientsRodolphe Thiébaut, Wafaa M El-Sadr, Nina Friis-Møller, et al.
Lancet (London, England)|August 8, 2006
HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysisMargaret T May, Jonathan A C Sterne, Dominique Costagliola, et al.
BMC Endocrine Disorders|November 19, 2022
Use of antibiotics and risk of type 2 diabetes, overweight and obesity: the Cardiovascular Risk in Young Finns Study and the national FINRISK studyJoel Nuotio, Teemu Niiranen, Tomi T Laitinen, et al.
European Journal of Clinical Nutrition|February 16, 2023
Evidence for protein leverage in a general population sample of children and adolescentsChristoph Saner, Alistair M Senior, Hanyue Zhang, et al.
The New England Journal of Medicine|November 25, 2003
Combination antiretroviral therapy and the risk of myocardial infarctionNina Friis-Møller, Caroline A Sabin, Rainer Weber, et al.
AIDS (London, England)|September 12, 2008
Treatment switches after viral rebound in HIV-infected adults starting antiretroviral therapy: multicentre cohort study, Katherine J Lee, David Dunn, et al.
The Lancet. Infectious Diseases|May 11, 2020
From the micro to the macro to improve health: microorganism ecology and society in teaching infectious disease epidemiologyMaryam Shahmanesh, Guy Harling, Cordelia E M Coltart, et al.
The Journal of Infectious Diseases|March 5, 2004
Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?E Fontas, F van Leth, C A Sabin, et al.
HIV Medicine|April 25, 2006
The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D StudyM G Law, N Friis-Møller, W M El-Sadr, et al.
Pageof 52

Showing results (441-450 of 520) with videos related to

Sort By:
Pageof 52
AIDS (London, England)|June 26, 2007
Increased duration of viral suppression is associated with lower viral rebound rates in patients with previous treatment failuresAndrew A Benzie, Loveleen K Bansi, Caroline A Sabin, et al.
Antiviral Therapy|December 1, 2005
Predictors of hypertension and changes of blood pressure in HIV-infected patientsRodolphe Thiébaut, Wafaa M El-Sadr, Nina Friis-Møller, et al.
Lancet (London, England)|August 8, 2006
HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysisMargaret T May, Jonathan A C Sterne, Dominique Costagliola, et al.
BMC Endocrine Disorders|November 19, 2022
Use of antibiotics and risk of type 2 diabetes, overweight and obesity: the Cardiovascular Risk in Young Finns Study and the national FINRISK studyJoel Nuotio, Teemu Niiranen, Tomi T Laitinen, et al.
European Journal of Clinical Nutrition|February 16, 2023
Evidence for protein leverage in a general population sample of children and adolescentsChristoph Saner, Alistair M Senior, Hanyue Zhang, et al.
The New England Journal of Medicine|November 25, 2003
Combination antiretroviral therapy and the risk of myocardial infarctionNina Friis-Møller, Caroline A Sabin, Rainer Weber, et al.
AIDS (London, England)|September 12, 2008
Treatment switches after viral rebound in HIV-infected adults starting antiretroviral therapy: multicentre cohort study, Katherine J Lee, David Dunn, et al.
The Lancet. Infectious Diseases|May 11, 2020
From the micro to the macro to improve health: microorganism ecology and society in teaching infectious disease epidemiologyMaryam Shahmanesh, Guy Harling, Cordelia E M Coltart, et al.
The Journal of Infectious Diseases|March 5, 2004
Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?E Fontas, F van Leth, C A Sabin, et al.
HIV Medicine|April 25, 2006
The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D StudyM G Law, N Friis-Møller, W M El-Sadr, et al.
Pageof 52